Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3698
Journal Title: The effect of 12 months' treatment with eicosapentaenoic acid in five children with Cystic Fibrosis
Authors: Thies, Nick H.
SWH Author: Thies, Nick H.
Keywords: Adolescent
Child
Clinical Article
Cystic Fibrosis
Docosahexaenoic Acid
Drug
Drug Efficacy
Female
Fish Oil
Hospitalization
Human
Eicosapentaenoic Acid
Lung Disease
Lung Function
Omega 3 Fatty Acid
Oral Drug Administration
Priority Journal
Supplementation
Issue Date: 1997
Date Accessioned: 2023-04-12T02:09:38Z
Date Available: 2023-04-12T02:09:38Z
Url: https://doi.org/10.1111/j.1440-1754.1997.tb01615.x
Description Affiliation: N.H. Thies, 238 Lava Street, Warrnambool Base Hospital, Victoria, Australia.
Format Startpage: 349-351
Source Volume: 33
Issue Number: 4
Date: 1997
Abstract: Five children with cystic fibrosis (CF) and chronic suppurative lung disease had eicosapentaenoic acid (EPA) supplementation for 12 months. Outcome was measured by the change in frequency of admissions/bed days while taking EPA compared to the previous 2 years: Although no significant changes occurred, there is an indication that this treatment may benefit children who don't have end-stage disease. Further studies are indicated in the use of this neglected mode of treatment.
URI: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3698
Journal Title: Journal of Paediatrics and Child Health
Type: Journal Article
Appears in Collections:SWH Staff Publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing